These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 35378273)

  • 21. Revisiting macrophages in ovarian cancer microenvironment: development, function and interaction.
    El-Arabey AA; Alkhalil SS; Al-Shouli ST; Awadalla ME; Alhamdi HW; Almanaa TN; Mohamed SSEM; Abdalla M
    Med Oncol; 2023 Apr; 40(5):142. PubMed ID: 37039909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNAs in ovarian cancer biology and therapy resistance.
    van Jaarsveld MT; Helleman J; Berns EM; Wiemer EA
    Int J Biochem Cell Biol; 2010 Aug; 42(8):1282-90. PubMed ID: 20083225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition.
    Thibault B; Castells M; Delord JP; Couderc B
    Cancer Metastasis Rev; 2014 Mar; 33(1):17-39. PubMed ID: 24357056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromatin target of protein arginine methyltransferase regulates invasion, chemoresistance, and stemness in epithelial ovarian cancer.
    Feng X; Li L; Wang L; Luo S; Bai X
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30910850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment.
    Nisar S; Yousuf P; Masoodi T; Wani NA; Hashem S; Singh M; Sageena G; Mishra D; Kumar R; Haris M; Bhat AA; Macha MA
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CXC Chemokine Signaling in Progression of Epithelial Ovarian Cancer: Theranostic Perspectives.
    Huang X; Hao J; Tan YQ; Zhu T; Pandey V; Lobie PE
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of cancer-associated mesothelial cells in the progression and therapy of ovarian cancer.
    Zheng A; Wei Y; Zhao Y; Zhang T; Ma X
    Front Immunol; 2022; 13():1013506. PubMed ID: 36268019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. microRNAs as biomarkers of ovarian cancer.
    Zhang H; Lu B
    Expert Rev Anticancer Ther; 2020 May; 20(5):373-385. PubMed ID: 32326768
    [No Abstract]   [Full Text] [Related]  

  • 30. Rethinking the chemokine cascade in brain metastasis: Preventive and therapeutic implications.
    Maurya SK; Khan P; Rehman AU; Kanchan RK; Perumal N; Mahapatra S; Chand HS; Santamaria-Barria JA; Batra SK; Nasser MW
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):914-930. PubMed ID: 34968667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adipose-derived stem cells in ovarian cancer progression, metastasis, and chemoresistance.
    Zhang W; Torres-Rojas C; Yue J; Zhu BM
    Exp Biol Med (Maywood); 2021 Aug; 246(16):1810-1815. PubMed ID: 34229470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemokines and cytokines: Axis and allies in prostate cancer pathogenesis.
    Mughees M; Kaushal JB; Sharma G; Wajid S; Batra SK; Siddiqui JA
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):497-512. PubMed ID: 35181473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advancements in therapeutic targeting of the Warburg effect in refractory ovarian cancer: A promise towards disease remission.
    Tyagi K; Mandal S; Roy A
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188563. PubMed ID: 33971276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The emerging roles of exosomes in anti-cancer drug resistance and tumor progression: An insight towards tumor-microenvironment interaction.
    Jena BC; Mandal M
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188488. PubMed ID: 33271308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional regulation of chemokine expression in ovarian cancer.
    Singha B; Gatla HR; Vancurova I
    Biomolecules; 2015 Mar; 5(1):223-43. PubMed ID: 25790431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in Cancer.
    Reyes ME; de La Fuente M; Hermoso M; Ili CG; Brebi P
    Front Immunol; 2020; 11():901. PubMed ID: 32499779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune Tumor Microenvironment in Ovarian Cancer Ascites.
    Almeida-Nunes DL; Mendes-Frias A; Silvestre R; Dinis-Oliveira RJ; Ricardo S
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of Tumor Associated Macrophages (TAMs) in Cancer Progression, Chemoresistance, Angiogenesis and Metastasis - Current Status.
    Dallavalasa S; Beeraka NM; Basavaraju CG; Tulimilli SV; Sadhu SP; Rajesh K; Aliev G; Madhunapantula SV
    Curr Med Chem; 2021; 28(39):8203-8236. PubMed ID: 34303328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microvesicles and chemokines in tumor microenvironment: mediators of intercellular communications in tumor progression.
    Bian X; Xiao YT; Wu T; Yao M; Du L; Ren S; Wang J
    Mol Cancer; 2019 Mar; 18(1):50. PubMed ID: 30925930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.
    Mehraj U; Ganai RA; Macha MA; Hamid A; Zargar MA; Bhat AA; Nasser MW; Haris M; Batra SK; Alshehri B; Al-Baradie RS; Mir MA; Wani NA
    Cell Oncol (Dordr); 2021 Dec; 44(6):1209-1229. PubMed ID: 34528143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.